Dupilumab – July 2026

  • Injection 200 mg in 1.14 mL single dose pre-filled syringe
  • Injection 200 mg in 1.14 mL single dose pre-filled pen
  • Injection 300 mg in 2 mL single dose pre-filled syringe
  • Injection 300 mg in 2 mL single dose pre-filled pen

  • Brand names:
    • Dupixent®
  • Pharmaceutical Company:
    • SANOFI-AVENTIS AUSTRALIA PTY LTD
  • Condition/Indication: Chronic severe atopic dermatitis
  • Meeting Date: July 2026

Last updated
13 November 2026